AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
BALTIMORE -- Intravaginal misoprostol was as effective for ending second-trimester pregnancies as intraamniotic prostaglandin [F.sub.2[alpha]] in a controlled study with 217 women.
Although intraamniotic prostaglandin [F.sub.2[alpha]] ([PGF.sub.2[alpha]]) has been the standard method for medically induced, second-trimester pregnancy termination, intravaginal infusion of misoprostol has been increasingly used despite little evidence from head-to-head comparisons of the two methods. The results of this study show that intravaginal misoprostol is as effective as the alternative while causing less vomiting, Dr. Hani A. Akoury said while presenting a poster at the annual meeting of the American Society of Human Genetics.
Misoprostol is indicated solely for the prevention of gastric ulcers associated with the use of nonsteroidal anti-inflammatory drugs.
The study involved 217 women at week 15-24 of pregnancy at three university teaching hospitals in Toronto. They were randomized to three treatment groups: Women in one group received an intraamniotic infusion of 40 mg [PGF.sub.2[alpha]] followed 4 hours later by a continuous infusion of oxytocin for 24 hours or until labor began. The women in the second group received 400 [micro]g misoprostol as an intravaginal infusion every 4 ...
Source: HighBeam Research, Misoprostol works as well as [PGF.sub.2[alpha]] for abortion....